Surgical Management of a Giant Left Sinus of Valsalva Aneurysm with Coronary Artery Abnormality

Giant left sinus of valsalva aneurysm

Authors

  • Long Song, MD Department of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, China
  • Chukwuemeka Daniel Iroegbu, MD Department of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, China
  • Chengming Fan, MD Department of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, China
  • Xinmin Zhou, MD Department of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, China

DOI:

https://doi.org/10.1532/hsf.3643

Keywords:

Left Sinus of Valsalva Aneurysm, surgery

Abstract

Coronary insufficiency caused by unruptured left sinus of Valsalva aneurysm (SVA) is exceedingly rare in the literature. Herein, we present a successful surgically treated case of giant left SVA with severe aortic regurgitation and coronary insufficiency, thus introducing a tailored valve-sparing aortic root repair technique.

References

Abe T, Kada K, Murakami H, et al. 2012. Unruptured left coronary sinus of valsalva aneurysm causing mitral valve obstruction. Circulation 125:e389-91.

Chiu P, Miller DC. 2016. Evolution of surgical therapy for Stanford acute type A aortic dissection. Ann Cardiothorac Surg 5:275-95.

Cho YH, Yong HS, Baek MJ, et al. 2013. Sinus of valsalva aneurysm from left sinus: value of angioscopic view of a 3-dimensional computed tomographic angiography. Circ Cardiovasc Imaging 6:156-7.

David TE. 2016. Aortic valve sparing in different aortic valve and aortic root conditions. J Am Coll Cardiol 68:654-64.

Feldman DN, Roman MJ. 2006. Aneurysms of the sinuses of valsalva. Cardiology 106:73-81.

Grande KJ, Cochran RP, Reinhall PG, Kunzelman KS. 1998. Stress variations in the human aortic root and valve: the role of anatomic asymmetry. Ann Biomed Eng 26:534-45.

Jiang Z, Tang M, Liu H, Mei J. 2017. Surgical management of giant left sinus of valsalva aneurysm causing left anterior descending coronary artery occlusion. Ann Thorac Surg 104:e27-e9.

Martinez-Comendador J, Gualis J, Martin CE, Santamaria A. 2013. Left main coronary artery compression by a left sinus of Valsalva aneurysm. Interact Cardiovasc Thorac Surg 16:713-4.

Ott DA. 2006. Aneurysm of the sinus of valsalva. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 165-76.

Pedroza AJ, Brewer ZE, Lee AM. 2018. Emergency valve-sparing aortic root replacement and coronary artery bypass grafting for giant left sinus of valsalva aneurysm presenting as acute coronary syndrome. J Thorac Cardiovasc Surg 156:e81-e4.

Urbanski PP, Zhan X, Hijazi H, Zacher M, Diegeler A. 2012. Valve-sparing aortic root repair without down-sizing of the annulus. J Thorac Cardiovasc Surg 143:294-302.

Yacoub MH, Aguib H, Gamrah MA, et al. 2018. Aortic root dynamism, geometry, and function after the remodeling operation: Clinical relevance. J Thorac Cardiovasc Surg 156:951-62 e2.

Published

2021-03-25

How to Cite

Song, L., Iroegbu, C. D., Fan, C., & Zhou, X. (2021). Surgical Management of a Giant Left Sinus of Valsalva Aneurysm with Coronary Artery Abnormality: Giant left sinus of valsalva aneurysm. The Heart Surgery Forum, 24(2), E296-E298. https://doi.org/10.1532/hsf.3643

Issue

Vol. 24 No. 2 (2021)

Section

Articles

Author Disclosure & Copyright Transfer Agreement

In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.

A current form follows:

The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.

However, Publisher grants back to the author(s) the following:

  1. The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
  2. The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
  3. The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
  4. The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
  5. The right to make oral presentations of material from this work.

Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.

I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.

I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).

I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.

Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).